| Product Code: ETC9930159 | Publication Date: Sep 2024 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United Arab Emirates (UAE) Pharmacogenetic Testing Market Overview |
3.1 United Arab Emirates (UAE) Country Macro Economic Indicators |
3.2 United Arab Emirates (UAE) Pharmacogenetic Testing Market Revenues & Volume, 2021 & 2031F |
3.3 United Arab Emirates (UAE) Pharmacogenetic Testing Market - Industry Life Cycle |
3.4 United Arab Emirates (UAE) Pharmacogenetic Testing Market - Porter's Five Forces |
3.5 United Arab Emirates (UAE) Pharmacogenetic Testing Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 United Arab Emirates (UAE) Pharmacogenetic Testing Market Revenues & Volume Share, By Gene Type, 2021 & 2031F |
3.7 United Arab Emirates (UAE) Pharmacogenetic Testing Market Revenues & Volume Share, By Drug Type, 2021 & 2031F |
3.8 United Arab Emirates (UAE) Pharmacogenetic Testing Market Revenues & Volume Share, By Sample, 2021 & 2031F |
3.9 United Arab Emirates (UAE) Pharmacogenetic Testing Market Revenues & Volume Share, By Therapeutic Area, 2021 & 2031F |
3.10 United Arab Emirates (UAE) Pharmacogenetic Testing Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.11 United Arab Emirates (UAE) Pharmacogenetic Testing Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 United Arab Emirates (UAE) Pharmacogenetic Testing Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness among healthcare providers and patients about the benefits of pharmacogenetic testing |
4.2.2 Rising adoption of personalized medicine in the UAE healthcare system |
4.2.3 Growing focus on precision medicine and targeted therapies in the region |
4.3 Market Restraints |
4.3.1 High initial costs associated with pharmacogenetic testing |
4.3.2 Limited reimbursement policies for pharmacogenetic testing in the UAE |
4.3.3 Lack of standardized guidelines and regulations for pharmacogenetic testing |
5 United Arab Emirates (UAE) Pharmacogenetic Testing Market Trends |
6 United Arab Emirates (UAE) Pharmacogenetic Testing Market, By Types |
6.1 United Arab Emirates (UAE) Pharmacogenetic Testing Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 United Arab Emirates (UAE) Pharmacogenetic Testing Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 United Arab Emirates (UAE) Pharmacogenetic Testing Market Revenues & Volume, By Whole Genome Sequencing, 2021- 2031F |
6.1.4 United Arab Emirates (UAE) Pharmacogenetic Testing Market Revenues & Volume, By Whole Exome Sequencing, 2021- 2031F |
6.1.5 United Arab Emirates (UAE) Pharmacogenetic Testing Market Revenues & Volume, By Array-Based Tests, 2021- 2031F |
6.1.6 United Arab Emirates (UAE) Pharmacogenetic Testing Market Revenues & Volume, By Single Gene Tests, 2021- 2031F |
6.2 United Arab Emirates (UAE) Pharmacogenetic Testing Market, By Gene Type |
6.2.1 Overview and Analysis |
6.2.2 United Arab Emirates (UAE) Pharmacogenetic Testing Market Revenues & Volume, By CYP2C19, 2021- 2031F |
6.2.3 United Arab Emirates (UAE) Pharmacogenetic Testing Market Revenues & Volume, By CYP2D6, 2021- 2031F |
6.2.4 United Arab Emirates (UAE) Pharmacogenetic Testing Market Revenues & Volume, By CYP2C9 and VKORC1, 2021- 2031F |
6.2.5 United Arab Emirates (UAE) Pharmacogenetic Testing Market Revenues & Volume, By CYP1A2, 2021- 2031F |
6.2.6 United Arab Emirates (UAE) Pharmacogenetic Testing Market Revenues & Volume, By HLA-B*1502, 2021- 2031F |
6.2.7 United Arab Emirates (UAE) Pharmacogenetic Testing Market Revenues & Volume, By HLA-B*5701, 2021- 2031F |
6.3 United Arab Emirates (UAE) Pharmacogenetic Testing Market, By Drug Type |
6.3.1 Overview and Analysis |
6.3.2 United Arab Emirates (UAE) Pharmacogenetic Testing Market Revenues & Volume, By Prescription Drugs, 2021- 2031F |
6.3.3 United Arab Emirates (UAE) Pharmacogenetic Testing Market Revenues & Volume, By Nutraceuticals, 2021- 2031F |
6.3.4 United Arab Emirates (UAE) Pharmacogenetic Testing Market Revenues & Volume, By Recreational Drugs, 2021- 2031F |
6.3.5 United Arab Emirates (UAE) Pharmacogenetic Testing Market Revenues & Volume, By Herbal Supplements, 2021- 2031F |
6.3.6 United Arab Emirates (UAE) Pharmacogenetic Testing Market Revenues & Volume, By Vitamins, 2021- 2031F |
6.3.7 United Arab Emirates (UAE) Pharmacogenetic Testing Market Revenues & Volume, By Over-the-Counter Medications, 2021- 2031F |
6.4 United Arab Emirates (UAE) Pharmacogenetic Testing Market, By Sample |
6.4.1 Overview and Analysis |
6.4.2 United Arab Emirates (UAE) Pharmacogenetic Testing Market Revenues & Volume, By Blood, 2021- 2031F |
6.4.3 United Arab Emirates (UAE) Pharmacogenetic Testing Market Revenues & Volume, By Saliva, 2021- 2031F |
6.5 United Arab Emirates (UAE) Pharmacogenetic Testing Market, By Therapeutic Area |
6.5.1 Overview and Analysis |
6.5.2 United Arab Emirates (UAE) Pharmacogenetic Testing Market Revenues & Volume, By Cardiology, 2021- 2031F |
6.5.3 United Arab Emirates (UAE) Pharmacogenetic Testing Market Revenues & Volume, By Gastroenterology, 2021- 2031F |
6.5.4 United Arab Emirates (UAE) Pharmacogenetic Testing Market Revenues & Volume, By Anesthesiology, 2021- 2031F |
6.5.5 United Arab Emirates (UAE) Pharmacogenetic Testing Market Revenues & Volume, By Genomics, 2021- 2031F |
6.5.6 United Arab Emirates (UAE) Pharmacogenetic Testing Market Revenues & Volume, By Endocrinology, 2021- 2031F |
6.5.7 United Arab Emirates (UAE) Pharmacogenetic Testing Market Revenues & Volume, By Immunology & Hypersensitivity, 2021- 2031F |
6.5.8 United Arab Emirates (UAE) Pharmacogenetic Testing Market Revenues & Volume, By Others, 2021- 2031F |
6.5.9 United Arab Emirates (UAE) Pharmacogenetic Testing Market Revenues & Volume, By Others, 2021- 2031F |
6.6 United Arab Emirates (UAE) Pharmacogenetic Testing Market, By Application |
6.6.1 Overview and Analysis |
6.6.2 United Arab Emirates (UAE) Pharmacogenetic Testing Market Revenues & Volume, By Clinical Practice, 2021- 2031F |
6.6.3 United Arab Emirates (UAE) Pharmacogenetic Testing Market Revenues & Volume, By Drug Development, 2021- 2031F |
6.6.4 United Arab Emirates (UAE) Pharmacogenetic Testing Market Revenues & Volume, By Drug Regulation, 2021- 2031F |
6.7 United Arab Emirates (UAE) Pharmacogenetic Testing Market, By End User |
6.7.1 Overview and Analysis |
6.7.2 United Arab Emirates (UAE) Pharmacogenetic Testing Market Revenues & Volume, By Healthcare Providers, 2021- 2031F |
6.7.3 United Arab Emirates (UAE) Pharmacogenetic Testing Market Revenues & Volume, By Pharmaceutical & Biotechnology Companies, 2021- 2031F |
6.7.4 United Arab Emirates (UAE) Pharmacogenetic Testing Market Revenues & Volume, By Others, 2021- 2031F |
6.7.5 United Arab Emirates (UAE) Pharmacogenetic Testing Market Revenues & Volume, By Others, 2021- 2031F |
7 United Arab Emirates (UAE) Pharmacogenetic Testing Market Import-Export Trade Statistics |
7.1 United Arab Emirates (UAE) Pharmacogenetic Testing Market Export to Major Countries |
7.2 United Arab Emirates (UAE) Pharmacogenetic Testing Market Imports from Major Countries |
8 United Arab Emirates (UAE) Pharmacogenetic Testing Market Key Performance Indicators |
8.1 Number of healthcare facilities offering pharmacogenetic testing services in the UAE |
8.2 Percentage increase in the number of pharmacogenetic tests conducted annually |
8.3 Adoption rate of pharmacogenetic testing by healthcare professionals in the UAE |
9 United Arab Emirates (UAE) Pharmacogenetic Testing Market - Opportunity Assessment |
9.1 United Arab Emirates (UAE) Pharmacogenetic Testing Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 United Arab Emirates (UAE) Pharmacogenetic Testing Market Opportunity Assessment, By Gene Type, 2021 & 2031F |
9.3 United Arab Emirates (UAE) Pharmacogenetic Testing Market Opportunity Assessment, By Drug Type, 2021 & 2031F |
9.4 United Arab Emirates (UAE) Pharmacogenetic Testing Market Opportunity Assessment, By Sample, 2021 & 2031F |
9.5 United Arab Emirates (UAE) Pharmacogenetic Testing Market Opportunity Assessment, By Therapeutic Area, 2021 & 2031F |
9.6 United Arab Emirates (UAE) Pharmacogenetic Testing Market Opportunity Assessment, By Application, 2021 & 2031F |
9.7 United Arab Emirates (UAE) Pharmacogenetic Testing Market Opportunity Assessment, By End User, 2021 & 2031F |
10 United Arab Emirates (UAE) Pharmacogenetic Testing Market - Competitive Landscape |
10.1 United Arab Emirates (UAE) Pharmacogenetic Testing Market Revenue Share, By Companies, 2024 |
10.2 United Arab Emirates (UAE) Pharmacogenetic Testing Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here